Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events

被引:259
作者
Mehta, Nehal N. [1 ,2 ]
Yu, YiDing [1 ]
Pinnelas, Rebecca [1 ]
Krishnamoorthy, Parasuram [1 ]
Shin, Daniel B. [3 ,4 ]
Troxel, Andrea B. [2 ,4 ]
Gelfand, Joel M. [2 ,3 ,4 ]
机构
[1] Univ Penn, Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
Inflammation; Major adverse cardiac events; Psoriasis; Risk factors; TRANSIENT ISCHEMIC ATTACK; MYOCARDIAL-INFARCTION; VASCULAR-DISEASES; CORONARY-ARTERY; PRIMARY-CARE; STROKE; COHORT; MORTALITY; CONSENSUS;
D O I
10.1016/j.amjmed.2011.03.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Recent studies suggest that psoriasis, particularly if severe, may be a risk factor for major adverse cardiac events, such as myocardial infarction, stroke, and mortality from cardiovascular disease. We compared the risk of major adverse cardiac events between patients with psoriasis and the general population and estimated the attributable risk of severe psoriasis. METHODS: We performed a cohort study in the General Practice Research Database. Severe psoriasis was defined as receiving a psoriasis diagnosis and systemic therapy (N = 3603). Up to 4 patients without psoriasis were selected from the same practices and start dates for each patient with psoriasis (N = 14,330). RESULTS: Severe psoriasis was a risk factor for major adverse cardiac events (hazard ratio 1.53; 95% confidence interval, 1.26-1.85) after adjusting for age, gender, diabetes, hypertension, tobacco use, and hyperlipidemia. After fully adjusted analysis, severe psoriasis conferred an additional 6.2% absolute risk of 10-year major adverse cardiac events. CONCLUSION: Severe psoriasis confers an additional 6.2% absolute risk of a 10-year rate of major adverse cardiac events compared with the general population. This potentially has important therapeutic implications for cardiovascular risk stratification and prevention in patients with severe psoriasis. Future prospective studies are needed to validate these findings. (C) 2011 Elsevier Inc. All rights reserved. circle The American Journal of Medicine (2011) 124, 775.e1-775.e6
引用
收藏
页码:775.e1 / 775.e6
页数:6
相关论文
共 27 条
[1]   Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK [J].
Abuabara, K. ;
Azfar, R. S. ;
Shin, D. B. ;
Neimann, A. L. ;
Troxel, A. B. ;
Gelfand, J. M. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (03) :586-592
[2]   Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study [J].
Ahlehoff, O. ;
Gislason, G. H. ;
Charlot, M. ;
Jorgensen, C. H. ;
Lindhardsen, J. ;
Olesen, J. B. ;
Abildstrom, S. Z. ;
Skov, L. ;
Torp-Pedersen, C. ;
Hansen, P. R. .
JOURNAL OF INTERNAL MEDICINE, 2011, 270 (02) :147-157
[3]   More than skin deep: atherosclerosis as a systemic manifestation of psoriasis [J].
Alexandroff, A. B. ;
Pauriah, M. ;
Camp, R. D. R. ;
Lang, C. C. ;
Struthers, A. D. ;
Armstrong, D. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (01) :1-7
[4]   Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis [J].
Balci, D. D. ;
Balci, A. ;
Karazincir, S. ;
Ucar, E. ;
Iyigun, U. ;
Yalcin, F. ;
Seyfeli, E. ;
Inandi, T. ;
Egilmez, E. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (01) :1-6
[5]   Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis [J].
Brauchli, Y. B. ;
Jick, S. S. ;
Miret, M. ;
Meier, C. R. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (05) :1048-1056
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[8]   Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions [J].
Davidovici, Batya B. ;
Sattar, Naveed ;
Joerg, Prinz C. ;
Puig, Luis ;
Emery, Paul ;
Barker, Jonathan N. ;
van de Kerkhof, Peter ;
Stahle, Mona ;
Nestle, Frank O. ;
Girolomoni, Giampiero ;
Krueger, James G. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (07) :1785-1796
[9]   AJC Editor's Consensus: Psoriasis and Coronary Artery Disease [J].
Friedewald, Vincent E. ;
Cather, Jennifer C. ;
Gelfand, Joel A. ;
Gordon, Kenneth B. ;
Gibbons, Gary H. ;
Grundy, Scott M. ;
Jarratt, Michael T. ;
Krueger, James G. ;
Ridker, Paul M. ;
Stone, Neil ;
Roberts, William C. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12) :1631-1643
[10]   Prevalence and treatment of psoriasis in the United Kingdom - A population-based study [J].
Gelfand, JM ;
Weinstein, R ;
Porter, SB ;
Neimann, AL ;
Berlin, JA ;
Margolis, D .
ARCHIVES OF DERMATOLOGY, 2005, 141 (12) :1537-1541